SCHEMBL5252995

SCHEMBL5252995

N#Cc1ccc2c(c1)CN(CC1CCN(CC(O)c3ccc(F)cc3)CC1)C2=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.48
HTR2A P28223 1/20 0.48
TMEM97 Q5BJF2 1/20 0.48
PRMT5 O14744 2/20 0.45
WDR77 Q9BQA1 2/20 0.45
GMNN O75496 1/20 0.44
TP53 P04637 1/20 0.44
CYP3A4 P08684 1/20 0.44
ALOX15 P16050 1/20 0.44
TSHR P16473 1/20 0.44
NFKB1 P19838 1/20 0.44
THPO P40225 1/20 0.44
MTOR P42345 1/20 0.44
BLM P54132 1/20 0.44
GRIN1 Q05586 1/20 0.44
GRIN2B Q13224 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
CCR3 P51677 1/20 0.41
KDM4E B2RXH2 2/20 0.39
GRM5 P41594 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5252998 1.00 HTR1A (0.48) HTR1AHTR2ATMEM97PRMT5WDR77
Hydrochloric Acid SCHEMBL5251207 0.99 HTR1A (0.47) HTR1AHTR2ATMEM97PRMT5WDR77
Hydrochloric Acid SCHEMBL5251211 0.99 HTR1A (0.47) HTR1AHTR2ATMEM97PRMT5WDR77
SCHEMBL5255967 0.90 HTR1A (0.53) HTR1AHTR2ATMEM97PRMT5WDR77
SCHEMBL5255966 0.90 HTR1A (0.53) HTR1AHTR2ATMEM97PRMT5WDR77
Hydrochloric Acid SCHEMBL5253389 0.89 HTR1A (0.52) HTR1AHTR2ATMEM97PRMT5WDR77
Hydrochloric Acid SCHEMBL5253393 0.89 HTR1A (0.52) HTR1AHTR2ATMEM97PRMT5WDR77
SCHEMBL5247857 0.86 HTR1A (0.50) HTR1AHTR2ATMEM97PRMT5WDR77
SCHEMBL5247863 0.86 HTR1A (0.50) HTR1AHTR2ATMEM97PRMT5WDR77
SCHEMBL5252651 0.86 GMNN (0.56) HTR1AHTR2ATMEM97PRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1260512-B1 NOVEL CYCLIC AMIDE DERIVATIVES MITSUBISHI PHARMA CORP (JP) 2007-07-04 EP disclosed
US-7166617-B2 Cyclic amide derivatives MITSUBISHI PHARMA CORPORATION (JP) 2007-01-23 US disclosed
US-20030212094-A1 Novel cyclic amide derivatives MITSUBISHI PHARMA CORPORATION (JP) 2003-11-13 US disclosed
EP-1260512-A1 NOVEL CYCLIC AMIDE DERIVATIVES Mitsubishi Pharma Corporation (JP) 2002-11-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212094-A1 Novel cyclic amide derivatives SIGMAR1, OPRM1, OPRD1 HTR1A 79/4885HTR2A 153/4885TMEM97 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.